About Us
- - Who We Are
    The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization headquartered in Washington, D.C., representing the most accomplished individuals in the fields of medical and biological engineering
- - President’s Circle
  - Past Presidents
    AIMBE's Past Presidents include some of the premier leaders in the medical and biological engineering community
Events
- - 2024 Annual Event
    March 24-25, 2024
- - Earl Bakken Lecture Series
    The Earl Bakken Lecture is presented at AIMBE’s Annual Event in honor of Honorary Fellow and pioneer, Earl Bakken. Each year, a new type of innovation is highlighted.
- - AIMBE Public Policy Institute
    Learn from Washington Insiders about how public policy impacts Biomedical engineering!
College of Fellows
- College of Fellows
  The College of Fellows consists of almost 3,000 individuals who are the outstanding leaders, engineers, entrepreneurs, and innovators in medical and biological engineering
- Nominations & Election
  Fellows are nominated each year by their peers and represent the top 2% of the medical and biological engineering community
- Fellowbook News
  AIMBE Fellowbook collects news stories highlighting the members of the AIMBE College of Fellows
- Fellow Directory
  Browse and search the Fellows by Name, Title, Organization, and Class Year
Councils & Committees
- Academic Council
  AIMBE’s Academic Council includes 100 U.S. universities offering medical and biological engineering education at the graduate and undergraduate levels.
- Council of Societies
  AIMBE’s mechanism to coordinate and enhance interaction among 15 scientific organizations in medical and biological engineering
- Industry Council
  The companies and key corporate leaders of the bioengineering revolution are represented in AIMBE
- Diversity & Inclusion Committee
  Achieving greater diversity and inclusion within AIMBE, and providing leadership training and greater opportunities to minorities in MBE.
- Committee for the UnderRepresented and Marginalized
  To recognize the contributions of underrepresented and marginalized groups (URM) in MBE.
- International Committee
  The Top Medical and Biological Engineers from around the World
Public Policy
- Advocate
  Everything you need to get involved, research and contact your policy-makers, and followup through lab tours and visits
- Our Work
  Learn about AIMBE's ongoing public policy work and past accomplishments that have communicated the value of medical and biological engineering
Awards
- Pierre Galletti Award
  This Award was established in 1999 by the AIMBE to honor our Founding Member and Past President.
- AIMBE Professional Impact Award
  In recognition of outstanding commitment to Mentoring, Diversity, Equity, and Inclusion, Leadership, and/or Education
For Students
- Navigate the Circuit
  Our newest site designed to help students of all levels on their path to medical and biological engineering
- Milestones of Innovation
  The Milestones of Innovation highlight some of the greatest accomplishments in medical and biological engineering.
- Student Policy Resources
  Information for students interested in science policy on why and how to get engaged in advocacy efforts supporting medical and biological engineering.
- AIMBE Public Policy Institute
  Learn from Washington Insiders about how public policy impacts Biomedical engineering!
Nominations
- College of Fellows
  Fellows are nominated each year by their peers and represent the top 2% of the medical and biological engineering community
- Emerging Leaders
  Each year, AIMBE will select ~20 emerging leaders who will be recognized during AIMBE’s Annual Meeting.

About Us
- - Who We Are
    The American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization headquartered in Washington, D.C., representing the most accomplished individuals in the fields of medical and biological engineering
- - President’s Circle
  - Past Presidents
    AIMBE's Past Presidents include some of the premier leaders in the medical and biological engineering community
Events
- - 2024 Annual Event
    March 24-25, 2024
- - Earl Bakken Lecture Series
    The Earl Bakken Lecture is presented at AIMBE’s Annual Event in honor of Honorary Fellow and pioneer, Earl Bakken. Each year, a new type of innovation is highlighted.
- - AIMBE Public Policy Institute
    Learn from Washington Insiders about how public policy impacts Biomedical engineering!
College of Fellows
- College of Fellows
  The College of Fellows consists of almost 3,000 individuals who are the outstanding leaders, engineers, entrepreneurs, and innovators in medical and biological engineering
- Nominations & Election
  Fellows are nominated each year by their peers and represent the top 2% of the medical and biological engineering community
- Fellowbook News
  AIMBE Fellowbook collects news stories highlighting the members of the AIMBE College of Fellows
- Fellow Directory
  Browse and search the Fellows by Name, Title, Organization, and Class Year
Councils & Committees
- Academic Council
  AIMBE’s Academic Council includes 100 U.S. universities offering medical and biological engineering education at the graduate and undergraduate levels.
- Council of Societies
  AIMBE’s mechanism to coordinate and enhance interaction among 15 scientific organizations in medical and biological engineering
- Industry Council
  The companies and key corporate leaders of the bioengineering revolution are represented in AIMBE
- Diversity & Inclusion Committee
  Achieving greater diversity and inclusion within AIMBE, and providing leadership training and greater opportunities to minorities in MBE.
- Committee for the UnderRepresented and Marginalized
  To recognize the contributions of underrepresented and marginalized groups (URM) in MBE.
- International Committee
  The Top Medical and Biological Engineers from around the World
Public Policy
- Advocate
  Everything you need to get involved, research and contact your policy-makers, and followup through lab tours and visits
- Our Work
  Learn about AIMBE's ongoing public policy work and past accomplishments that have communicated the value of medical and biological engineering
Awards
- Pierre Galletti Award
  This Award was established in 1999 by the AIMBE to honor our Founding Member and Past President.
- AIMBE Professional Impact Award
  In recognition of outstanding commitment to Mentoring, Diversity, Equity, and Inclusion, Leadership, and/or Education
For Students
- Navigate the Circuit
  Our newest site designed to help students of all levels on their path to medical and biological engineering
- Milestones of Innovation
  The Milestones of Innovation highlight some of the greatest accomplishments in medical and biological engineering.
- Student Policy Resources
  Information for students interested in science policy on why and how to get engaged in advocacy efforts supporting medical and biological engineering.
- AIMBE Public Policy Institute
  Learn from Washington Insiders about how public policy impacts Biomedical engineering!
Nominations
- College of Fellows
  Fellows are nominated each year by their peers and represent the top 2% of the medical and biological engineering community
- Emerging Leaders
  Each year, AIMBE will select ~20 emerging leaders who will be recognized during AIMBE’s Annual Meeting.

image_alt_text

8

Robert S. Ward

AIMBE College of Fellows Class of 2003

For unique and innovative contributions to the development and utilization of polyurethanes in medical devices.

DoD Funds Clinical Trial of Seraph Blood Filter to Treat COVID-19

Via MD+DI Online | June 9, 2020

The Department of Defense is funding a clinical trial of a COVID-19 treatment using ExThera Medical’s Seraph 100 Blood filter.

The device was selected to be in the multi-center randomized clinical trial because it showed encouraging preliminary results in critically ill COVID-19 patients at a military hospital in the U.S. and 14 other hospitals in Europe. Investigators at the Uniformed Services University in Bethesda will run the trial of the Martinez, CA-based company’s device. Initial reports indicate Seraph 100 stabilizes blood pressure and inflammatory biomarkers that correlate with poor patient outcome: IL-6, Ferritin, D-dimers, LDH, and Nt-proBNP, all decreased during Seraph 100 treatments of COVID-19 patients.

In a release about DoD’s funding, it was stated that it appears as if the Seraph 100 helps improve patient outcomes by providing additional time for supportive care while reducing the sources of inflammation and possibly preventing further damage by reducing SARS-CoV-2 virus/RNA in the bloodstream… Continue reading.

Follow Fellow (RSS)